Unknown

Dataset Information

0

SGLT2 Inhibitors for Type 2 Diabetes Mellitus Treatment.


ABSTRACT: SGLT2 inhibitors are plausible second-line drugs that provide powerful additional A1c-lowering effects while inducing weight loss without hypoglycemia.

SUBMITTER: Plodkowski RA 

PROVIDER: S-EPMC6375399 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

SGLT2 Inhibitors for Type 2 Diabetes Mellitus Treatment.

Plodkowski Raymond A RA   McGarvey Megan E ME   Huribal Heather M HM   Reisinger-Kindle Keith K   Kramer Bradley B   Solomon Mordecai M   Nguyen Quang T QT  

Federal practitioner : for the health care professionals of the VA, DoD, and PHS 20151001 Suppl 11


SGLT2 inhibitors are plausible second-line drugs that provide powerful additional A<sub>1c</sub>-lowering effects while inducing weight loss without hypoglycemia. ...[more]

Similar Datasets

| S-EPMC3978932 | biostudies-other
| S-EPMC9115977 | biostudies-literature
| S-EPMC10067557 | biostudies-literature
| S-EPMC4160579 | biostudies-literature
| S-EPMC9571431 | biostudies-literature
| S-EPMC3889318 | biostudies-literature
| S-EPMC10570247 | biostudies-literature
| S-EPMC4065283 | biostudies-literature
| S-EPMC6965597 | biostudies-literature
| S-EPMC8967154 | biostudies-literature